Literature DB >> 7937790

Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells.

J P DiSanto1, F Rieux-Laucat, A Dautry-Varsat, A Fischer, G de Saint Basile.   

Abstract

X chromosome-linked severe combined immunodeficiency disease (SCIDX1) is characterized by the absence of T-cell and natural killer cell development and results from molecular mutations of the interleukin 2 receptor (IL-2R) gamma chain. The IL-2R gamma chain is a common component of the IL-2, IL-4, and IL-7 receptor systems, which may explain the severe immunophenotype in SCIDX1. We have previously described an atypical SCIDX1 syndrome demonstrating poorly functioning peripheral T cells, which we hypothesized to represent a variant allele at the SCIDX1 locus. We now demonstrate that a splice site mutation in the IL-2R gamma gene is responsible for this atypical SCIDX1. Aberrant RNA splicing resulted in the generation of two IL-2R gamma transcripts: an abundant, nonfunctional isoform containing a small intronic insertion and a second functional isoform with a single amino acid substitution present in limited amounts. Radiolabeled IL-2 binding studies revealed a 5-fold decreased level of expression of functional high-affinity IL-2Rs, which correlated with the quantity of full-length IL-2R gamma transcripts. Further analysis of the T-cell antigen receptor beta-chain repertoire of the patient's T cells demonstrated oligoclonality in multiple V beta families, thus strongly suggesting that the defect in the IL-2R gamma chain generated a limited number of peripheral T-cell clones. This atypical SCIDX1 patient demonstrates that certain IL-2R gamma chain abnormalities can also result in partial immunodeficiency phenotypes, potentially through differential effects on the IL-2, IL-4, or IL-7 receptor systems.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937790      PMCID: PMC44833          DOI: 10.1073/pnas.91.20.9466

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Receptor-mediated endocytosis of interleukin 2 in a human tumor T cell line. Degradation of interleukin 2 and evidence for the absence of recycling of interleukin receptors.

Authors:  V Duprez; A Dautry-Varsat
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

2.  Functional status of interleukin 2 receptors expressed by immature (Lyt-2-/L3T4-) thymocytes.

Authors:  J W Lowenthal; R C Howe; R Ceredig; H R MacDonald
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

3.  Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNA.

Authors:  M Aebi; H Hornig; R A Padgett; J Reiser; C Weissmann
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

4.  Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation.

Authors:  J M Puck; R L Nussbaum; M E Conley
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

5.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

6.  Importance of IL-2 receptors in intra-thymic generation of cells expressing T-cell receptors.

Authors:  E J Jenkinson; R Kingston; J J Owen
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

7.  Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes.

Authors:  M Kondo; T Takeshita; M Higuchi; M Nakamura; T Sudo; S Nishikawa; K Sugamura
Journal:  Science       Date:  1994-03-11       Impact factor: 47.728

8.  Absence of growth by most receptor-expressing fetal thymocytes in the presence of interleukin-2.

Authors:  H von Boehmer; A Crisanti; P Kisielow; W Haas
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

9.  Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4.

Authors:  B Sadlack; R Kühn; H Schorle; K Rajewsky; W Müller; I Horak
Journal:  Eur J Immunol       Date:  1994-01       Impact factor: 5.532

10.  Expression and function of interleukin-2 receptors on immature thymocytes.

Authors:  D H Raulet
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

View more
  22 in total

Review 1.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  Interleukin-2 signaling and inherited immunodeficiency.

Authors:  N A Cacalano; J A Johnston
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 3.  Severe combined immunodeficiencies (SCID).

Authors:  A Fischer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 4.  Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.

Authors:  F Candotti; J J O'Shea; A Villa
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

6.  Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment.

Authors:  Federica Cattaneo; Mike Recher; Stefania Masneri; Sachin N Baxi; Claudia Fiorini; Francesca Antonelli; Christian A Wysocki; Jose G Calderon; Hermann Eibel; Angela R Smith; Francisco A Bonilla; Erdyni Tsitsikov; Silvia Giliani; Luigi D Notarangelo; Sung-Yun Pai
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

7.  Clinical characteristics and genetic profiles of 44 patients with severe combined immunodeficiency (SCID): report from Shanghai, China (2004-2011).

Authors:  Chun-Mei Yao; Xiao-Hua Han; Yi-Dan Zhang; Hui Zhang; Ying-Ying Jin; Rui-Ming Cao; Xi Wang; Quan-Hua Liu; Wei Zhao; Tong-Xin Chen
Journal:  J Clin Immunol       Date:  2012-12-19       Impact factor: 8.317

8.  Screening for mutations causing X-linked severe combined immunodeficiency in the IL-2R gamma chain gene by single-strand conformation polymorphism analysis.

Authors:  P A Clark; T Lester; S Genet; A M Jones; R Hendriks; R J Levinsky; C Kinnon
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

9.  Ralstonia pickettii-induced ataxia in immunodeficient mice.

Authors:  Marion Berard; Christine Medaille; Meredith Simon; Stéphanie Serre; Kathleen Pritchett-Corning; Virginie Dangles-Marie
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

10.  A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.

Authors:  Taco W Kuijpers; Ester M M van Leeuwen; Barbara H Barendregt; Paul Klarenbeek; Daan J aan de Kerk; Paul A Baars; Machiel H Jansen; Niek de Vries; René A W van Lier; Mirjam van der Burg
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.